Home Cart Sign in  
Chemical Structure| 324-94-7 Chemical Structure| 324-94-7

Structure of 324-94-7

Chemical Structure| 324-94-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 324-94-7 ]

CAS No. :324-94-7
Formula : C12H9FO
M.W : 188.20
SMILES Code : OC1=CC=C(C2=CC=C(F)C=C2)C=C1
MDL No. :MFCD01830385
InChI Key :QSJNKJGPJVOGPK-UHFFFAOYSA-N
Pubchem ID :345420

Safety of [ 324-94-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 324-94-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 14
Num. arom. heavy atoms 12
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 53.86
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

20.23 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.3
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.62
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

3.48
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.46
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.17

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.65
Solubility 0.0417 mg/ml ; 0.000222 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.4
Solubility 0.0748 mg/ml ; 0.000398 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.62
Solubility 0.00451 mg/ml ; 0.000024 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.11 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.43

Application In Synthesis of [ 324-94-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 324-94-7 ]

[ 324-94-7 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 324-94-7 ]
  • [ 835-69-8 ]
  • 2
  • [ 324-94-7 ]
  • [ 535-11-5 ]
  • [ 1764-60-9 ]
  • 3
  • [ 462-06-6 ]
  • [ 540-38-5 ]
  • [ 324-94-7 ]
  • [ 321-62-0 ]
  • [ 64465-61-8 ]
  • 4
  • [ 106-41-2 ]
  • [ 352-33-0 ]
  • [ 92-88-6 ]
  • [ 324-94-7 ]
  • [ 398-23-2 ]
  • 5
  • [ 324-94-7 ]
  • [ 1026851-39-7 ]
  • [ 135136-30-0 ]
  • 6
  • [ 324-94-7 ]
  • 4-[2-(4-Propyl-cyclohexyl)-ethyl]-cyclohexanecarbonyl chloride [ No CAS ]
  • 4-[2-(4-Propyl-cyclohexyl)-ethyl]-cyclohexanecarboxylic acid 4'-fluoro-biphenyl-4-yl ester [ No CAS ]
  • 8
  • [ 540-38-5 ]
  • [ 460-00-4 ]
  • [ 324-94-7 ]
  • [ 398-23-2 ]
  • 9
  • [ 352-34-1 ]
  • [ 108-95-2 ]
  • [ 10540-41-7 ]
  • [ 324-94-7 ]
  • [ 80254-62-2 ]
  • 10
  • [ 330-84-7 ]
  • [ 92-69-3 ]
  • [ 324-94-7 ]
  • [ 134023-60-2 ]
  • [ 80254-62-2 ]
YieldReaction ConditionsOperation in experiment
55% With dichloro(1,3-bis(2,6-bis(3-pentyl)phenyl)imidazolin-2-ylidene)(3-chloropyridyl)palladium(II); potassium hydroxide; In 1,4-dioxane; at 70℃; for 5h;Inert atmosphere; Schlenk technique; General procedure: Referring to Scheme IX, a 10-mL round bottom flask equipped with a stir-bar was charged with 4-bromophenol (500 mg, 2.89 mmol, 1.0 equiv.), Pd-PEPPSI-IPent (45 mg, 2 mol %), 2- naphthylboronic acid (745 mg, 4.33 mmol, 1.5 equiv.), and potassium hydroxide (970 mg, 17.3 mmol, 6.0 equiv.). The flask was sealed with a rubber septum and purged with argon (3x). (0466) Dioxane (6.0 mL) was then added via syringe and the reaction was stirred at 70C for 5 h. The reaction mixture was diluted with diethyl ether (75 mL) and washed with 0.1N HCl (2 x 25 mL), water (2x 25 mL) and brine (25 mL). Dried over anhydrous MgSO4 and filtered. The contents were concentrated under reduced pressure and the crude was passed through a pad of silica washing with ethyl acetate to give 3-(naphthalen-2-yl)phenol (569 mg, 89%) as an off-white solid 1H-NMR (400 MHz, CDCl3) ^: 7.98 (s, 1H), 7.87 (m, 3H), 7.72 (m, 1H), 7.60 (d, 2H), 7.48 (m, 2H), 6.95 (d, 2H).
  • 13
  • aqueous diazotized 4'-fluoro-4-amino-biphenyl [ No CAS ]
  • [ 324-94-7 ]
  • 14
  • [ 106-41-2 ]
  • [ 1765-93-1 ]
  • [ 324-94-7 ]
YieldReaction ConditionsOperation in experiment
67% With palladium diacetate; potassium carbonate; In water; at 25℃; for 2h; Distilled water and 3 ml 4-Bromo phenol 173 mg (1 mmol) and 4-fluorophenylboronic acid 147 mg (1 mmol) was dissolved potassium carbonate and 415mg (3 mmol) and palladium acetate 1 mg to put 2 hours at room temperature ( was stirred at 25 ). the reaction is complete the solid is filtered dichloromethane to give washed several times, the organic layer was dried over anhydrous magnesium sulfate, then filtered and dried under reduced pressure and purified by column chromatography (diethyl ether / hexane = 1/9) to obtain to give the title compound (127 mg, yield = 67%).
  • 16
  • [ 1765-93-1 ]
  • [ 106-48-9 ]
  • [ 324-94-7 ]
  • 17
  • [ 324-94-7 ]
  • [ 52191-15-8 ]
  • [ 877615-09-3 ]
  • 19
  • [ 74124-79-1 ]
  • [ 324-94-7 ]
  • C17H12FNO5 [ No CAS ]
  • 21
  • [ 324-94-7 ]
  • 4'-fluorobiphenyl-4-yl methyl(3-(pyridin-4-yl)benzyl)carbamate [ No CAS ]
  • 22
  • [ 324-94-7 ]
  • 3-{4-[2-(4'-fluoro-biphenyl-4-yloxy)-ethoxy]-phenyl}-2-methoxy-propionic acid [ No CAS ]
  • 23
  • [ 324-94-7 ]
  • 2-ethoxy-3-{4-[2-(4'-fluoro-biphenyl-4-yloxy)-ethoxy]-phenyl}-propionic acid [ No CAS ]
  • 26
  • [ 324-94-7 ]
  • (Z)-3-{4-[2-(4'-Fluoro-biphenyl-4-yloxy)-ethoxy]-phenyl}-2-methoxy-acrylic acid ethyl ester [ No CAS ]
  • 27
  • [ 324-94-7 ]
  • (Z)-2-Ethoxy-3-{4-[2-(4'-fluoro-biphenyl-4-yloxy)-ethoxy]-phenyl}-acrylic acid ethyl ester [ No CAS ]
  • 28
  • [ 324-94-7 ]
  • 2-cyclopentyloxy-3-{4-[2-(4'-fluoro-biphenyl-4-yloxy)-ethoxy]-phenyl}-propionic acid [ No CAS ]
  • 29
  • [ 324-94-7 ]
  • (Z)-2-Cyclopentyloxy-3-{4-[2-(4'-fluoro-biphenyl-4-yloxy)-ethoxy]-phenyl}-acrylic acid ethyl ester [ No CAS ]
  • 31
  • [ 106-41-2 ]
  • isobutyl halide [ No CAS ]
  • [ 324-94-7 ]
 

Historical Records

Technical Information

Categories